In a new study, Yale researchers identify the targets in the human body to which pathogens transmitted by mosquitoes, ticks, and other vectors bind. Their findings, they say, could help address the rising threat of vector-borne ...
Jul 9, 2024
0
44
Vaccines provide a front-line defense against dangerous viruses, training adaptive immune cells to identify and fight specific pathogens.
Jul 8, 2024
0
39
To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy.
Jul 8, 2024
0
6
In June 2023, Uresa A. (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which is a serious autoimmune ...
Jul 8, 2024
0
45
A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model ...
Jul 8, 2024
0
61
Researchers led by Yasuhiro Murakawa at the RIKEN Center for Integrative Medical Sciences (IMS) and Kyoto University in Japan and IFOM ETS in Italy have discovered several rare types of helper T cells that are associated ...
Jul 4, 2024
0
34
Stem cells are like the emergency tool kit of the human body. They have the unique ability to form into other types of specialized cells—from immune cells to brain cells. They can divide and regenerate indefinitely to repair ...
Jul 4, 2024
0
54
Many vaccines are only partially effective, have waning efficacy, or do not work well in the very young or the very old. For more than a decade, Ofer Levy, MD, Ph.D., and David Dowling, Ph.D., in the Precision Vaccines Program ...
Jul 3, 2024
0
30
Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that ...
Jul 3, 2024
0
5
Dexamethasone is one of the most important drugs in the treatment of severe COVID-19, but patients respond very differently to the therapy. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité—Universitätsmedizin ...
Jul 3, 2024
0
100
